Literature DB >> 9688455

Fungal infections in neutropenia: current problems and chemotherapeutic control.

D W Warnock1.   

Abstract

Invasive fungal infection is a significant problem in neutropenic individuals. The commonest causes of infection are Aspergillus and Candida spp., although a growing number of other organisms (including species of Fusarium and Trichosporon) have been implicated. The clinical manifestations of these infections are described here, and diagnostic problems are discussed. The role of lipid-based formulations of amphotericin B, and of the triazole compounds, itraconazole and fluconazole, in the treatment and prevention of fungal infection is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688455     DOI: 10.1093/jac/41.suppl_4.95

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

Review 1.  Therapy for fungal infections in leukemia.

Authors:  R E Segal; G Y Minamoto
Journal:  Curr Oncol Rep       Date:  2001-05       Impact factor: 5.075

2.  Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Jerry W Pickering; Howard W Sant; Catherine A P Bowles; William L Roberts; Gail L Woods
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.

Authors:  Hong Xin
Journal:  Vaccine       Date:  2015-11-25       Impact factor: 3.641

4.  In vitro activities and postantifungal effects of the potent dolastatin 10 derivative auristatin PHE.

Authors:  T Woyke; G R Pettit; G Winkelmann; R K Pettit
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults.

Authors:  Boualem Sendid; Denis Caillot; Bénédicte Baccouch-Humbert; Lena Klingspor; Monique Grandjean; Alain Bonnin; Daniel Poulain
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

6.  Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.

Authors:  Lynn Purkins; Nolan Wood; Katie Greenhalgh; Michael J Allen; Stuart D Oliver
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

7.  Plasma levels of Transforming Growth Factor Beta in HIV-1 patients with oral candidiasis.

Authors:  A Izadi; G Asadikaram; N Nakhaee; S Hadizadeh; A Ayatollahi Mousavi
Journal:  Curr Med Mycol       Date:  2015-03

8.  Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion.

Authors:  Zhen Qin; Aurélie Bouteau; Christopher Herbst; Botond Z Igyártó
Journal:  bioRxiv       Date:  2022-08-20

9.  Forward Modeling of the Coumarin Antifungals; SPR/SAR Based Perspective.

Authors:  Saeed Soltani; Shima Dianat; Soroush Sardari
Journal:  Avicenna J Med Biotechnol       Date:  2009-07

10.  Metagenomic analysis of bloodstream infections in patients with acute leukemia and therapy-induced neutropenia.

Authors:  P Gyarmati; C Kjellander; C Aust; Y Song; L Öhrmalm; C G Giske
Journal:  Sci Rep       Date:  2016-03-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.